Colini Baldeschi G, Cobianchi M R
UOSD Terapia Antalgica, Azienda Ospedaliera S. Giovanni Addolorata, Roma, Italia.
Minerva Med. 2012 Jun;103(3):177-82.
The objective of this study was to compare the analgesic efficacy and tolerability of tramadol hydrochloride compared with codeine phosphate in combination with paracetamol in patients with moderate-to-severe low back pain caused by osteoarthritis. In fact, while paracetamol is the analgesic of choice for this disease, in cases where this treatment may be ineffective, the therapeutic choice involves the addition of weak opioids. Due to the chronic nature of the disease, these drugs represent a safer alternative compared to anti-inflammatory drugs (NSAIDs) and selective inhibitors of cyclooxygenase 2 (COX-2).
In the present study two combination treatments were considered: codeine-paracetamol (respectively 30 mg and 500 mg) and tramadol-paracetamol (respectively 37.5 mg and 325 mg). The study duration was 4 weeks and involved 38 patients (mean age 64.7 years). The effectiveness of the two treatments was assessed in terms of analgesic efficacy, tolerability and safety.
The results recorded after a week of treatment and at the end of the study showed a difference in favour of codeine-paracetamol association which showed slightly higher values in pain improvement and, above all, was better tolerated in terms of adverse events and drop out.
The study, although conducted on a limited number of patients and for a relatively short time, demonstrates the greater efficacy and tolerability of the association codeine-paracetamol compared to tramadol-paracetamol.
本研究的目的是比较盐酸曲马多与磷酸可待因联合对乙酰氨基酚在骨关节炎所致中重度腰痛患者中的镇痛效果和耐受性。事实上,虽然对乙酰氨基酚是该疾病的首选镇痛药,但在该治疗可能无效的情况下,治疗选择包括添加弱阿片类药物。由于该疾病的慢性性质,与抗炎药(非甾体抗炎药)和环氧化酶2(COX-2)选择性抑制剂相比,这些药物是更安全的选择。
在本研究中,考虑了两种联合治疗:可待因 - 对乙酰氨基酚(分别为30毫克和500毫克)和曲马多 - 对乙酰氨基酚(分别为37.5毫克和325毫克)。研究持续时间为4周,涉及38名患者(平均年龄64.7岁)。从镇痛效果、耐受性和安全性方面评估了两种治疗的有效性。
治疗一周后和研究结束时记录的结果显示,可待因 - 对乙酰氨基酚联合治疗更具优势,在疼痛改善方面显示出略高的值,最重要的是,在不良事件和退出方面耐受性更好。
该研究虽然在有限数量的患者中进行且时间相对较短,但证明了可待因 - 对乙酰氨基酚联合治疗比曲马多 - 对乙酰氨基酚联合治疗具有更高的疗效和耐受性。